NCT03180684 2023-08-25Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)Inovio PharmaceuticalsPhase 2 Completed33 enrolled 19 charts